Dois-je éviter retinoyl tripeptide-35 pendant la grossesse ? | VeriMom
Ingredient is described in patents/databases as the product of retinoic acid and tripeptide-35 (i.e. contains a retinoid moiety), which creates a structural alert for retinoid-associated reproductive risk; no harmonised CLP classification, no EU Annex II/III listing, and no peer‑reviewed reproductive/developmental studies for this specific compound were located. Evidence: ingredient descriptions/patents identify it as retinoyl (retinoic acid) conjugate. Sources searched found no SCCS/CIR opinions or PubMed toxicology studies.
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinoyl tripeptide-35 est-il sûr pendant la grossesse ?
- Ingredient is described in patents/databases as the product of retinoic acid and tripeptide-35 (i.e. contains a retinoid moiety), which creates a structural alert for retinoid-associated reproductive risk; no harmonised CLP classification, no EU Annex II/III listing, and no peer‑reviewed reproductive/developmental studies for this specific compound were located. Evidence: ingredient descriptions/patents identify it as retinoyl (retinoic acid) conjugate. Sources searched found no SCCS/CIR opinions or PubMed toxicology studies.
- retinoyl tripeptide-35 est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: presence of a retinoid moiety raises class-based concern. No data were found on milk transfer or lactation-specific studies for this compound. No regulatory restriction (Annex II/III) or harmonised H‑codes for this specific ingredient were found.
- retinoyl tripeptide-35 est-il sûr pour la peau de bébé ?
- No infant-specific studies located. Because adult topical absorption is plausible (retinoid moiety, low molecular-weight peptide conjugates sometimes penetrate), exposure for infants (0–3 yr) is increased by +1 per your rules. No evidence was found that the ingredient is non‑absorbable or that it does not release retinoic acid in vivo.
- Comment VeriMom évalue-t-il retinoyl tripeptide-35 ?
- VeriMom évalue retinoyl tripeptide-35 à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à retinoyl tripeptide-35 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à retinoyl tripeptide-35 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.